Marker Therapeutics appoints Kathryn Penkus Corzo to Board; CEO granted 250,000 options

Marker Therapeutics, Inc.

Kathryn Penkus Corzo appointed to Board effective Nov 1, 2025; she brings 30+ years of biopharma leadership.
Corzo currently President/COO of bit.bio; previously Head of Oncology Cell Therapy at Takeda Ventures.
Corzo received 147,611 stock options as non-employee director compensation, vesting over 36 months.
CEO Juan Vera granted 250,000 stock options, vesting annually over 4 years under the 2020 Plan.

item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-106669
form_type: 8-K
ticker: MRKR
cik: 0001094038
company_name: Marker Therapeutics, Inc.
filed_at: 2025-11-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.776762+00:00
generated_at: 2026-05-17T00:10:38.251328+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-106669
json_url: https://secwatch.observer/filing/0001104659-25-106669.json
markdown_url: https://secwatch.observer/filing/0001104659-25-106669.md
text_url: https://secwatch.observer/filing/0001104659-25-106669.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925106669/0001104659-25-106669-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925106669/tm2530129d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-106669

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.